2. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. The New England Journal of Medicine. 2006;355(26):2725-2732.
https://doi.org/10.1056/NEJMoa061115
3. Maki DG, Crnich CJ. Line sepsis in the ICU: prevention, diagnosis, and management. Seminars in Respiratory and Critical Care Medicine. 2003;24(1):23-36.
https://doi.org/10.1055/s-2003-37914
4. Kim EJ, Kwak YG, Kwak SH, Ko SH, Kweon OM, Kim ES, et al. Korean national healthcare-associated infections surveillance system, intensive care unit module report: summary of data from july 2020 through june 2021. Korean Journal of Healthcare-associated Infection Control and Prevention. 2023;28(1):64-77.
https://doi.org/10.14192/kjicp.2023.28.1.64
5. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proceedings. 2006;81(9):1159-1171.
https://doi.org/10.4065/81.9.1159
8. Park ES, Jin HY, Jeong SY, Kweon OM, Yoo SY, Park SY, et al. Healthcare-associated infection surveillance in small and medium sized hospitals. Korean Journal of Nosocomial Infection Control. 2011;16(2):54-62.
9. Gurney H, White J, Sweeney J, Valyko A, Washer L. Evaluation of hospital-onset bloodstream infections compared to central line-associated bloodstream infections at an acute, tertiary care hospital. American Journal of Infection Control. 2023;51(10):1120-1123.
https://doi.org/10.1016/j.ajic.2023.04.001
10. Sturm L, Service N, Bufalino A, Huang R, Sharma M, Erlinger T, et al. Is hospital-onset bloodstream infection (HOBSI) a useful measure to evaluate infection prevention progress? Infection Control & Hospital Epidemiology. 2020;41(S1):s307-s308.
https://doi.org/10.1017/ice.2020.894
11. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases. 2004;39(3):309-317.
https://doi.org/10.1086/421946
12. Mestre G, Berbel C, Tortajada P, Alarcia M, Coca R, Fernández MM, et al. Successful multifaceted intervention aimed to reduce short peripheral venous catheter-related adverse events: a quasiexperimental cohort study. American Journal of Infection Control. 2013;41(6):520-526.
https://doi.org/10.1016/j.ajic.2012.07.014
13. Pujol M, Hornero A, Saballs M, Argerich MJ, Verdaguer R, Cisnal M, et al. Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital. Journal of Hospital Infection. 2007;67(1):22-29.
https://doi.org/10.1016/j.jhin.2007.06.017
14. Ritchie S, Jowitt D, Roberts S. The Auckland city hospital device point prevalence survey 2005: utilisation and infectious complications of intravascular and urinary devices. The New Zealand Medical Journal. 2007;120(1260):U2683.
15. Vandenbos F, Basar A, Tempesta S, Fournier JP, Bertrand F, Vanesland L, et al. Relevance and complications of intravenous infusion at the emergency unit at Nice university hospital. Journal of Infection. 2003;46(3):173-176.
https://doi.org/10.1053/jinf.2002.1101
17. Delgado-Capel M, Gabillo A, Elias L, Yébenes JC, Sauca G, Capdevila JA. Características de la bacteriemia relacionada con catéter venoso periférico en un hospital general. Revista Española de Quimioterapia. 2012;25(2):129-133.
18. Mermel LA. Short-term peripheral venous catheter-related bloodstream infections: a systematic review. Clinical Infectious Diseases. 2017;65(10):1757-1762.
https://doi.org/10.1093/cid/cix562
20. Korean Society for Healthcare-associated Infection Control. Healthcare associated infection - control and prevention. 1st ed. Paju: Koonja Publishing Inc; 2023. p. 530-541.
24. Centers for Disease Control and Prevention. National Healthcare Safety Network (NHSN) Patient Safety Component Manual [Internet]. Atlanta: Centers for Disease Control and Prevention; 2023 [cited 2023 Dec 14]. Available from:
https://www.cdc.gov/nhsn/psc/index.html
26. Krishnan J, Gettler EB, Campbell M, Kalu IC, Seidelman J, Smith B, et al. Comparative epidemiology of hospital-onset bloodstream infections (HOBSIs) and central line-associated bloodstream infections (CLABSIs) across a three-hospital health system. Infection Control & Hospital Epidemiology. 2024;45(8):952-958.
https://doi.org/10.1017/ice.2024.38
27. Mitchell BG, Hall L, Halton K, MacBeth D, Gardner A. Time spent by infection control professionals undertaking healthcare associated infection surveillance: a multi-centred cross sectional study. Infection, Disease & Health. 2016;21(1):36-40.
https://doi.org/10.1016/j.idh.2016.03.003
28. Brownstein JS, Rader B, Astley CM, Tian H. Advances in artificial intelligence for infectious-disease surveillance. The New England Journal of Medicine. 2023;388(17):1597-1607.
https://doi.org/10.1056/NEJMra2119215
30. Rosenthal VD, Belkebir S, Zand F, Afeef M, Tanzi VL, Al-Abdely HM, et al. Six-year multicenter study on short-term peripheral venous catheters-related bloodstream infection rates in 246 intensive units of 83 hospitals in 52 cities of 14 countries of Middle East: Bahrain, Egypt, Iran, Jordan, Kingdom of Saudi Arabia, Kuwait, Lebanon, Morocco, Pakistan, Palestine, Sudan, Tunisia, Turkey, and United Arab Emirates—International Nosocomial Infection Control Consortium (INICC) findings. Journal of Infection and Public Health. 2020;13(8):1134-1141.
https://doi.org/10.1016/j.jiph.2020.03.012
32. Cho SY, Chung DR, Ryu JG, Choi JR, Ahn N, Kim S, et al. Impact of targeted interventions on trends in central line-associated bloodstream infection: a single-center experience from the Republic of Korea. Critical Care Medicine. 2017;45(6):e552-e558.
https://doi.org/10.1097/CCM.0000000000002306
35. Mitchell BG, Gardner A, Stone PW, Hall L, Pogorzelska-Maziarz M. Hospital staffing and health care-associated infections: a systematic review of the literature. The Joint Commission Journal on Quality and Patient Safety. 2018;44(10):613-622.
https://doi.org/10.1016/j.jcjq.2018.02.002
36. Saliba P, Hornero A, Cuervo G, Grau I, Jimenez E, Berbel D, et al. Interventions to decrease short-term peripheral venous catheter-related bloodstream infections: impact on incidence and mortality. The Journal of Hospital Infection. 2018;100(3):e178-e186.
https://doi.org/10.1016/j.jhin.2018.06.010
38. Tsuboi M, Hayakawa K, Mezaki K, Katanami Y, Yamamoto K, Kutsuna S, et al. Comparison of the epidemiology and microbiology of peripheral line- and central line-associated bloodstream infections. American Journal of Infection Control. 2019;47(2):208-210.
https://doi.org/10.1016/j.ajic.2018.08.016
39. Yoo S, Jung S, Kim G, Lim D, Sohn J, Kim J, et al. Interventions to prevent catheter-associated blood-stream infections: a multicenter study in Korea. Infection & Chemotherapy. 2010;42(4):216-222.
https://doi.org/10.3947/ic.2010.42.4.216
40. Thulstrup AM, Sørensen HT, Schønheyder HC, Møller JK, Tage-Jensen U. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clinical Infectious Diseases. 2000;31(6):1357-1361.
https://doi.org/10.1086/317494
43. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426-1437.
https://doi.org/10.1053/j.gastro.2013.02.042